Rovida Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-238,200
Closed -$40.7M 35
2021
Q4
$40.7M Hold
238,200
1.83% 23
2021
Q3
$38.5M Hold
238,200
1.63% 24
2021
Q2
$39.2M Hold
238,200
1.7% 22
2021
Q1
$39.1M Hold
238,200
1.83% 21
2020
Q4
$37.5M Hold
238,200
2.2% 15
2020
Q3
$35.4M Hold
238,200
2.45% 15
2020
Q2
$33.4M Buy
+238,200
New +$34.7M 3.22% 11
2020
Q1
Sell
-224,100
Closed -$32.7M 41
2019
Q4
$32.7M Buy
224,100
+40,000
+22% +$5.43M 1.73% 21
2019
Q3
$23.8M Buy
184,100
+15,600
+9% +$2.06M 1.41% 26
2019
Q2
$23.4M Hold
168,500
1.38% 28
2019
Q1
$23.6M Hold
168,500
1.6% 23
2018
Q4
$21.7M Hold
168,500
1.8% 22
2018
Q3
$23.3M Hold
168,500
1.7% 21
2018
Q2
$20.4M Hold
168,500
1.68% 21
2018
Q1
$21.6M Hold
168,500
2.03% 19
2017
Q4
$23.6M Hold
168,500
2.47% 18
2017
Q3
$21.9M Hold
168,500
2.32% 19
2017
Q2
$22.3M Hold
168,500
3.07% 17
2017
Q1
$21M Hold
168,500
3.58% 12
2016
Q4
$19.4M Buy
+168,500
New +$19.5M 4.32% 9

Other funds holding JNJ

Rovida Advisors's JNJ Position: Q1 2022 in Review

Rovida Advisors sold out of Johnson & Johnson (JNJ) in Q1 2022, closing a stake of 238,200 shares — an estimated $40.7M sold.

Rovida Advisors first reported a position in JNJ in Q4 2016 and held it in 20 quarters. The position peaked at $40.7M in Q4 2021. 3,676 funds tracked by Wall St. Rank hold JNJ as of Q1 2022.

  • Rovida Advisors reported no remaining Johnson & Johnson position as of Q1 2022 after selling out during the quarter.
  • Rovida Advisors sold 238,200 Johnson & Johnson shares in Q1 2022, an estimated $40.7M.
  • Rovida Advisors first reported a position in Johnson & Johnson in Q4 2016 and held it in 20 quarters.
  • Rovida Advisors's Johnson & Johnson position peaked at $40.7M in Q4 2021.
  • 3,676 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2022.

Based on Rovida Advisors's 13F filing for Q1 2022, filed 10 May 2022.